Franklin Street Advisors disclosed an exit from Intuitive Surgical (ISRG -0.92%) in its latest SEC filing for the quarter ended September 30, selling 42,601 shares for an estimated $23.2 million.What HappenedAccording to a filing with the Securities and Exchange Commission released on Thursday, Franklin Street Advisors sold its entire holding in Intuitive Surgical, divesting 42,601 shares. The estimated value of the transaction, calculated using the average market price during the quarter, was approximately ...

The surgical robotics pioneer could cement its leading position for years to come.Shares of Intuitive Surgical (ISRG -0.59%) are down about 26% from a peak they set earlier this year. While 2025 hasn't been a great year to hold shares of the surgical robotics pioneer, there's a very good reason to watch it closely from now through the end of 2026.Intuitive Surgical stock has delivered a 19,510% return since its initial public offering about 25 years ago. It did so by staying ahead of the competition, which ...

The medical sector in the United States has been heavily affected by a bearish cycle, driven by scandals surrounding the GLP-1 drugs used in weight loss solutions for consumers. As more companies are exposed to the manufacturing and distribution of these drugs, even some unrelated names have been dragged down by this broader sentiment, creating massive opportunities for those who are bold enough to look into the space. Intuitive Surgical TodayISRGIntuitive Surgical$439.20 -8.04 (-1.80%) 52-Week Range$425.0 ...

Two years can feel like an aeon. Especially when a company goes from not having money for staff salaries in 2023 to being listed on Nasdaq in 2025, garnering over a billion dollars in market cap.But Sudhir Srivastava is characteristically cool about where SSI International has landed in the medical-technology pantheon. Maybe because the cardiac surgeon-turned entrepreneur is “just taking a breather” after a challenging decade. Few believed he could deliver, let alone beat the American global leader Intuitiv ...

Core Viewpoint - SS Innovations International, Inc. has appointed Naveen Kumar Amar as the new Chief Financial Officer, effective September 24, 2025, succeeding Dr. Vishwa Srivastava, who will continue as CEO for Asia Pacific [1][2][3]. Company Overview - SS Innovations is focused on developing innovative surgical robotic technologies aimed at making robotic surgery affordable and accessible globally [5]. - The company’s product offerings include the proprietary "SSi Mantra" surgical robotic system and the "SSi Mudra" surgical instruments, which support various surgical procedures, including robotic cardiac surgery [5]. Leadership Appointment - Naveen Kumar Amar brings over 25 years of global finance leadership experience across various industries and geographies, with expertise in financial accounting, reporting, planning, analysis, and corporate finance [2][3]. - Amar has previously held significant positions, including Global CFO for Munch Ado India Private Ltd. and Head of Finance & Commercial for SpiceXpress [2][3]. Strategic Vision - The company aims to expand the global presence of its advanced, cost-efficient surgical robotic systems, particularly the SSi Mantra [3]. - Amar expressed his commitment to democratizing access to advanced surgical robotic care and driving growth to deliver sustainable long-term shareholder value [3]. Product Details - The SSi Mantra surgical robotic system features a modular design with 3 to 5 robotic arms, an ergonomic surgeon command center, and advanced imaging capabilities [6]. - It has been clinically validated in India for over 100 different types of surgical procedures, showcasing its versatility and effectiveness [6].

Trade Policy Developments - The U.S. administration has initiated investigations under Section 232 of the Trade Expansion Act, targeting imports of robotics, industrial machinery, and medical devices, which could lead to new tariffs ranging from 10% to 25% [3][6] - Companies like Intuitive Surgical (ISRG) have acknowledged these tariffs as a "material risk" to their 2025 earnings, potentially impacting healthcare costs and global supply chains [3][6] Monetary Policy Insights - Federal Reserve Bank of San Francisco President Mary Daly indicated that the U.S. economy still requires monetary support, with inflation moderate at around 2.4-2.5% excluding tariffs, while cautioning against further rate cuts [4][6] Housing Market Trends - KB Home (KBH) has revised its full-year 2025 revenue forecast downward to between $6.30 billion and $6.50 billion, citing a weaker-than-expected spring selling season and declining consumer confidence [5][6] Banking Sector Movements - Citigroup (C) has agreed to sell a 25% equity stake in its Mexican retail banking unit, Banamex, to local businessman Fernando Chico Pardo, marking progress in its divestiture strategy [7][6] Geopolitical Commentary - Brazilian President Luiz Inácio Lula da Silva emphasized the need for global cooperation and condemned the situation in Gaza, while also praising China's energy transition efforts [8][6]

Group 1: Northstar Clean Technologies - Northstar Clean Technologies has successfully produced high-quality solid asphalt pellets from end-of-life tear-off shingles at its Calgary facility, marking a significant milestone in its recycling operations [1] - This achievement builds on the company's previous success in producing liquid asphalt from manufacturing waste shingles, contributing to waste diversion from landfills and creating new market opportunities [2] Group 2: Memorial Care - Memorial Care has introduced the Intuitive Da Vinci 5 surgical system across its hospitals, becoming one of the first health systems in Southern California to adopt this advanced robotic technology [2] - The Da Vinci 5 system enhances surgeons' precision, control, and real-time digital integration, reinforcing Memorial Care's commitment to innovation and improved patient outcomes [2] Group 3: Eco-wave Power Global - Eco-wave Power Global has launched the first US onshore wave energy project at the Port of Los Angeles, marking a historic milestone for renewable energy in the country [3] - The demonstration site utilizes floaters to harness wave motion for electricity, laying the groundwork for future commercial-scale deployment and positioning the company as a leader in the US wave energy sector [3] Group 4: XDI Aerospace - XDI Aerospace has completed initial flight operations for its Sparrow and Kestrel subscale aircraft, marking key progress toward its full-scale Trifan 600 demonstrator [3] - Successful tests validated aerodynamic performance and stability, reducing development risk and keeping the program on track for future milestones [4]

Core Insights - Stereotaxis will showcase its surgical robotics technology at the HRX digital health conference from September 4-6, 2025, in Atlanta, Georgia, focusing on advancements in cardiovascular medicine [1] - CEO David Fischel will participate in a roundtable discussion and a panel session on innovative ablation techniques that leverage robotics and AI to enhance patient outcomes [2][3] Company Overview - Stereotaxis is a leader in surgical robotics for minimally invasive endovascular interventions, aiming to improve patient care through robotic precision and safety [4] - The company's technology has been utilized to treat over 150,000 patients globally, indicating a significant impact in the field of interventional cardiology [4]

[Music] Our world is aging. Between 2015 and 2050, the share of the world's population aged over 60 years will climb from 12% to 22%. That's one factor driving the growth in robotic healthcare.From 2023 to 2032, the global medical robotics market is predicted to almost quadruple to $63.8% billion. It's being boosted by artificial intelligence, which is generating the vast amounts of data needed to train robots. Robots are being developed across a wide variety of medical disciplines.In the UK, by 2035, 90% o ...

Core Insights - The company has received a new patent for its LIBERTY Endovascular Robotic System, bringing its total to 12 granted patents globally and 57 pending applications, which enhances its intellectual property portfolio [1][2] - The new patent allows for modular capabilities in the robotic system, potentially expanding its application to a wider range of endovascular procedures, thereby increasing the Total Addressable Market (TAM) [1][2] - The company aims to address over 6 million annual endovascular procedures in the U.S., significantly higher than the current estimate of 2.5 million procedures [2][3] Company Overview - Microbot Medical Inc. is a pre-commercial stage medical technology company focused on redefining endovascular robotics and improving patient care globally [4] - The company has developed the first single-use, fully disposable endovascular robotic system, which aims to remove traditional barriers to accessing advanced robotic systems [4]